Creative Medical Technology Holdings, Inc.
CELZ
$3.16
-$0.035-1.10%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -0.59% | -15.42% | -3.91% | 45.87% | 38.71% |
Total Depreciation and Amortization | 5.70% | 10.91% | 16.93% | 23.26% | 16.41% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 711.11% | 1,051.85% | 1,262.96% | -92.66% | -92.66% |
Change in Net Operating Assets | -197.34% | -154.35% | 101.59% | -53.08% | 181.15% |
Cash from Operations | -2.15% | -17.96% | 33.96% | 46.04% | 40.11% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -102.11% | -104.06% | 83.45% | 384.92% | 198.82% |
Cash from Investing | -102.11% | -104.06% | 83.45% | 384.92% | 198.82% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | 91.56% | 71.11% | 35.42% | -32.53% | -- |
Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 1,279.35% | 1,482.53% | 636.75% | -32.48% | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -126.63% | -156.37% | 150.96% | 114.07% | 118.45% |